Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited provides scientific services for the agriculture, food, pharmaceutical, and environment industries in Thailand. The company offers one stop and customized services, and quality, contaminants, additive services for meat and meat products, fats and oils, pet food, feedstuffs and feed raw materials, aquaculture aquat… Read more
Asia Medical & Agricultural Laboratory & Research Center PCL (AMARC) - Total Liabilities
Latest total liabilities as of September 2025: ฿107.18 Million THB
Based on the latest financial reports, Asia Medical & Agricultural Laboratory & Research Center PCL (AMARC) has total liabilities worth ฿107.18 Million THB as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Asia Medical & Agricultural Laboratory & Research Center PCL - Total Liabilities Trend (2018–2024)
This chart illustrates how Asia Medical & Agricultural Laboratory & Research Center PCL's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Asia Medical & Agricultural Laboratory & Research Center PCL Competitors by Total Liabilities
The table below lists competitors of Asia Medical & Agricultural Laboratory & Research Center PCL ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gyldendal ASA
OL:GYL
|
Norway | Nkr1.25 Billion |
|
Selic Corp Public Company Limited
BK:SELIC
|
Thailand | ฿1.43 Billion |
|
Ark Restaurants Corp
NASDAQ:ARKR
|
USA | $101.39 Million |
|
Hanchang Ind.Co.Ltd
KQ:079170
|
Korea | ₩10.88 Billion |
|
Prince Pharmaceutical Co., Ltd.
TWO:6935
|
Taiwan | NT$618.16 Million |
|
NGE Capital Limited
PINK:NGELF
|
USA | $684.00K |
|
Voyageur Mineral Explorers Corp
PINK:CPEFF
|
USA | $192.68K |
Liability Composition Analysis (2018–2024)
This chart breaks down Asia Medical & Agricultural Laboratory & Research Center PCL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Asia Medical & Agricultural Laboratory & Research Center PCL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Asia Medical & Agricultural Laboratory & Research Center PCL (2018–2024)
The table below shows the annual total liabilities of Asia Medical & Agricultural Laboratory & Research Center PCL from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ฿120.46 Million | -10.33% |
| 2023-12-31 | ฿134.34 Million | -11.30% |
| 2022-12-31 | ฿151.45 Million | -35.90% |
| 2021-12-31 | ฿236.29 Million | +5.58% |
| 2020-12-31 | ฿223.80 Million | +113.42% |
| 2019-12-31 | ฿104.87 Million | +4.55% |
| 2018-12-31 | ฿100.30 Million | -- |